Predictors of placebo response in three large clinical trials of the V1a receptor antagonist balovaptan in autism spectrum disorder

High rates of placebo response are increasingly implicated in failed autism spectrum disorder (ASD) clinical trials. Despite this, there are limited investigations of placebo response in ASD. We sought to identify baseline predictors of placebo response and quantify their influence on clinical scale...

Descripción completa

Detalles Bibliográficos
Autores principales: Tobe, Russell, Zhu, Yajing, Gleissl, Teresa, Rossomanno, Simona, Veenstra-VanderWeele, Jeremy, Smith, Janice, Hollander, Eric
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10267133/
https://www.ncbi.nlm.nih.gov/pubmed/37045991
http://dx.doi.org/10.1038/s41386-023-01573-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10267133/
https://www.ncbi.nlm.nih.gov/pubmed/37045991
http://dx.doi.org/10.1038/s41386-023-01573-9

Ejemplares similares